Jasper Therapeutics, Inc. (JSPR)
NASDAQ: JSPR · Real-Time Price · USD
0.930
-0.000 (-0.02%)
At close: Apr 28, 2026, 4:00 PM EDT
0.948
+0.019 (1.99%)
After-hours: Apr 28, 2026, 7:21 PM EDT
Jasper Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 26 | 51 | 321 | 88 | 22 | 389 | |
| Market Cap Growth | -58.35% | -84.03% | 264.33% | 294.73% | -94.26% | 210.66% | |
| Enterprise Value | -1 | 2 | 230 | -13 | -25 | 291 | |
| Last Close Price | 0.93 | 1.83 | 21.38 | 7.89 | 4.83 | 78.50 | |
| PB Ratio | 6.27 | 12.34 | 5.20 | 1.12 | 0.62 | 5.59 | |
| P/TBV Ratio | 6.27 | 12.34 | 5.20 | 1.12 | 0.62 | 5.59 | |
| Debt / Equity Ratio | 0.30 | 0.30 | 0.03 | 0.04 | 0.10 | 0.04 | |
| Net Debt / Equity Ratio | -6.61 | -6.61 | -1.13 | -1.07 | -0.96 | -1.18 | |
| Net Debt / EBITDA Ratio | 0.34 | 0.34 | 0.93 | 1.24 | 0.69 | 2.24 | |
| Net Debt / FCF Ratio | 0.36 | 0.36 | 1.11 | 1.61 | 0.75 | 2.27 | |
| Quick Ratio | 2.17 | 2.17 | 4.70 | 7.04 | 5.54 | 10.63 | |
| Current Ratio | 2.63 | 2.63 | 4.97 | 7.19 | 5.91 | 10.95 | |
| Return on Equity (ROE) | -230.31% | -230.31% | -101.73% | -112.67% | -71.44% | -78.33% | |
| Return on Assets (ROA) | -88.16% | -88.16% | -54.52% | -60.09% | -45.06% | -39.35% | |
| Return on Capital Employed (ROCE) | -361.30% | -361.30% | -117.90% | -83.40% | -124.00% | -43.00% | |
| Earnings Yield | -291.22% | -148.02% | -22.22% | -73.23% | -168.98% | -7.88% | |
| FCF Yield | -296.47% | -150.69% | -19.69% | -59.45% | -208.21% | -9.29% | |
| Buyback Yield / Dilution | -31.42% | -31.42% | -39.72% | -186.15% | -220.19% | -558.67% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.